Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wavelet Index monitoring of remimazolam sedation during spinal anesthesia
ChiCTR2400083367Phase 4Not yet recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Beijing Chaoyang Hospital. Primary endpoint: Correlation and consistency between Wavelet Index and MOAA/S. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2400083367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083367.